Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SPARC1210|DRUG: Reference1210
Sponsor: Sun Pharma Advanced Research Company Limited